domingo, 1 de noviembre de 2015

Hereditary Cancer in Clinical Practice

Hereditary Cancer  Impact Factor
Editors-in-Chief: Jan Lubinski (Poland), Rodney Scott (Australia), Rolf Sijmons (Netherlands)
Submit a manuscriptEditorial BoardAuthor InstructionsArticle Alerts
#BMC_Salutation#
We are writing to invite you to submit your next manuscript to Hereditary Cancer in Clinical Practice. To mark Breast Cancer Awareness month we would also like to share some highly accessed articles on breast cancer recently published in the journal.
Mutation analysis of PALB2 in BRCA1 and BRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, CanadaResearch 
Mutation analysis of PALB2 in BRCA1 andBRCA2-negative breast and/or ovarian cancer families from Eastern Ontario, Canada
Taila Hartley, Luca Cavallone, Nelly Sabbaghian, Rachel Silva-Smith, et al.
Abstract | Full Text | PDF
Beliefs about weight and breast cancer: an interview study with high risk women following a 12 month weight loss interventionResearch 
Beliefs about weight and breast cancer: an interview study with high risk women following a 12 month weight loss intervention
Claire E Wright, Michelle Harvie, Anthony Howell, D Evans, et al.
Abstract | Full Text | PDF
Cumulative BRCA mutation analysis in the Greek population confirms that homogenous ethnic background facilitates genetic testingReview
Cumulative BRCA mutation analysis in the Greek population confirms that homogenous ethnic background facilitates genetic testing
Alexandra Tsigginou, Fotios Vlachopoulos, Iordanis Arzimanoglou, Flora Zagouri, et al.
Abstract | Full Text | PDF

About the Journal
Hereditary Cancer in Clinical Practice is an open access journal that publishes articles of interest for the cancer genetics community and serves as a forum for the development of appropriate healthcare strategies.
Hereditary Cancer in Clinical Practice is the official journal of the International Hereditary Cancer Center and is published under the auspices of International Union Against Cancer.
Visit the journal’s website to find out more about the topics of interest.

Why publish with us?
-Expert international Editorial Board
-Rapid publication upon acceptance
-High quality peer review service
-Widest possible global dissemination of your research
92% of authors surveyed in 2014 would recommend the journal to a colleague
Keep up-to-date – register to get the latest articles straight to your inbox.
Best regards,
Jan LubinskiRodney Scott and Rolf Sijmons
Editors-in-Chief, Hereditary Cancer in Clinical Practice
For further information or enquiries please contact Customer Services at: info@biomedcentral.com.
BioMed Central Ltd, 236 Gray's Inn Road, London, WC1X 8HB, United Kingdom.
Part of Springer Science+Business Media. Privacy Policy

No hay comentarios: